Talphera

TLPHNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$74.216 M

$1.43 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$14.3M

Loss-making

Shares outstanding

50,049,824

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#321Gain TherapeuticsGANX$77.6M
#322Adicet BioACET$74.7M
#323TalpheraTLPH$74.2M
#324Acrivon TherapeuticsACRV$74.0M
#325Elicio TherapeuticsELTX$73.4M

Where these numbers come from

Share counts and financials for Talphera are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.